A new trading day began on Monday, with Atyr Pharma Inc (NASDAQ: ATYR) stock price up 2.00% from the previous day of trading, before settling in for the closing price of $3.25. ATYR’s price has ranged from $1.08 to $3.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 436.18%. Meanwhile, its annual earnings per share averaged 5.62%. With a float of $73.81 million, this company’s outstanding shares have now reached $75.80 million.
Let’s determine the extent of company efficiency that accounts for 59 employees. In terms of profitability, gross margin is -334.18%, operating margin of -10633.5%, and the pretax margin is -9846.26%.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.61%, while institutional ownership is 70.14%. The most recent insider transaction that took place on Jul 24 ’24, was worth 101,038. In this transaction Director of this company bought 52,300 shares at a rate of $1.93, taking the stock ownership to the 413,023 shares. Before that another transaction happened on Jul 22 ’24, when Company’s Director bought 41,052 for $1.74, making the entire transaction worth $71,500. This insider now owns 354,075 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 5.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 43.36% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Here are Atyr Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 425.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.77 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Looking closely at Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days average volume was 1.31 million, which is a jump from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 77.46%. Additionally, its Average True Range was 0.22.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 89.39%, which indicates a significant increase from 85.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.25% in the past 14 days, which was higher than the 74.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.11, while its 200-day Moving Average is $1.85. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $3.41. Second resistance stands at $3.50. The third major resistance level sits at $3.64. If the price goes on to break the first support level at $3.18, it is likely to go to the next support level at $3.04. Now, if the price goes above the second support level, the third support stands at $2.95.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
With a market capitalization of 251.28 million, the company has a total of 69,011K Shares Outstanding. Currently, annual sales are 350 K while annual income is -50,390 K. The company’s previous quarter sales were 240 K while its latest quarter income was -15,490 K.
